MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$773,702
EPS
-$0.43
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
308,747
141,597
257,199
187,808
General and administrative
499,359
663,457
475,908
527,466
Total operating expenses
808,106
805,054
733,107
715,274
Loss from operations
-808,106
-805,054
-733,107
-715,274
Change in fair value of warrant liability
108
-265
-498
-1,212
Interest income
34,512
38,801
47,966
47,325
Total other income
34,404
39,066
48,464
48,537
Net loss
-773,702
-765,988
-684,643
-666,737
Net loss attributable to common stockholders
-
-
-684,643
-666,737
Basic EPS
-0.43
-0.43
-0.583
-0.37
Diluted EPS
-0.43
-0.43
-0.583
-0.37
Basic Average Shares
1,796,755
1,795,260
1,174,869*
1,795,097
Diluted Average Shares
1,796,755
1,795,260
1,174,869*
1,795,097
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Interest income
$34,512
(418.67%↑ Y/Y)
Net loss
-$773,702
(-4.48%↓ Y/Y)
Total other income
$34,404
(355.32%↑ Y/Y)
Change in fair value of
warrant liability
$108
(111.97%↑ Y/Y)
Loss from operations
-$808,106
(-8.02%↓ Y/Y)
Total operating
expenses
$808,106
(8.02%↑ Y/Y)
General and
administrative
$499,359
(-10.26%↓ Y/Y)
Research and development
$308,747
(61.13%↑ Y/Y)
Buy us a coffee
Bone Biologics Corp (BBLG)
Bone Biologics Corp (BBLG)